(C) Reuters. The German share price index DAX graph is pictured at the stock exchange in Frankfurt
(Reuters) – European shares rebounded on Monday after a Wall Street-led rout in technology stocks kept global sentiment subdued in the previous week, with investors keeping a close watch on COVID-19 vaccine developments.
Australia expects to receive its first batches of a potential COVID-19 vaccine in January after a deal was struck with CSL (AX:CSL) to manufacture two vaccines – one developed by rival AstraZeneca (L:AZN) and Oxford University, and another in CSL’s own labs with the University of Queensland.
AstraZeneca rose 1.5%. The European healthcare sector index (SXDP) jumped 0.9%.
European shares start week on firm footing, vaccine developments eyed
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.